Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Boston Scientific revenue decreased from $10.7 billion in 2019 to $9.9 billion in 2020, a (7.7%) decrease.

Annual Revenue ($)

Boston Scientific revenue was $9.91 b in FY, 2020 which is a (7.7%) year over year decrease from the previous period.

Quarterly Revenue ($)

FY, 2018FY, 2019FY, 2020
Revenue$9.82 b$10.74 b$9.91 b
Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021
Revenue$2.49 b$2.63 b$2.71 b$2.54 b$2 b$2.66 b$2.75 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Boston Scientific revenue breakdown by business segment: 39.1% from Cardiovascular, 27.8% from Rhythm Management, 30.9% from MedSurg and 2.2% from Other

Boston Scientific revenue breakdown by geographic segment: 57.5% from U.S. and 42.5% from Other Countries

FY, 2020FY, 2019FY, 2018
Cardiovascular$3.88 b$4.21 b$3.78 b
Rhythm Management$2.75 b$3.14 b$3.04 b
MedSurg$3.07 b$3.31 b$3.01 b
All Other$219 m$81 m
FY, 2020FY, 2019FY, 2018
LACA$383 m
APAC$1.73 b
EMEA$2.18 b
U.S.$5.7 b$6.17 b$5.54 b
Other Countries$4.21 b$4.57 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu